Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
VTI vs XBI: how they differ
VTI and XBI hold 2% of their weight in the same names, and XBI returned more over the year.
Vanguard Total Stock Market Index Fund and State Street(R) SPDR(R) S&P(R) Biotech ETF.
What they hold in common
By the books each fund has filed, VTI and XBI hold 2% of their money in the same securities at the same weight.
| Holding | VTI | XBI |
|---|---|---|
| AbbVie Inc | 0.62% | 1.04% |
| Amgen Inc | 0.27% | 1.00% |
| Gilead Sciences Inc | 0.22% | 0.97% |
| Vertex Pharmaceuticals Inc | 0.17% | 1.06% |
| Regeneron Pharmaceuticals Inc | 0.09% | 0.96% |
| Alnylam Pharmaceuticals Inc | 0.06% | 0.96% |
| REVOLUTION Medicines Inc | 0.05% | 1.21% |
| Natera Inc | 0.05% | 1.17% |
| Biogen Inc | 0.04% | 1.03% |
| Moderna Inc | 0.04% | 1.41% |
| Insmed Inc | 0.03% | 1.08% |
| United Therapeutics Corp | 0.03% | 0.93% |
| Only in VTI | Only in XBI |
|---|---|
| NVIDIA Corp 6.37% | Roivant Sciences Ltd 1.16% |
| Apple Inc 5.88% | Alkermes PLC 1.11% |
| Microsoft Corp 3.84% | uniQure NV 1.03% |
| Amazon.com Inc 3.19% | CRISPR Therapeutics AG 1.02% |
| Alphabet Inc 2.90% | Biohaven Ltd 0.53% |
| Broadcom Inc 2.48% | Hyperliquid Strategies Inc 0.47% |
| Alphabet Inc 2.29% | Damora Therapeutics Inc 0.17% |
| Micron Technology Inc 1.80% | Prothena Corp PLC 0.13% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| VTI Vanguard Total Stock Market Index Fund | XBI State Street(R) SPDR(R) S&P(R) Biotech ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Vanguard | State Street |
| What it is | US total market | SPDR S&P Biotech |
| Total return, 1 year | +17.2% | +64.0% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −0.3 pts | +46.5 pts |
| Expense ratio | 0.03% | 0.35% |
| Already in the S&P 500 | 88.3% | 8.5% |
| Holdings | 3531 | 150 |
VTI in plain words
VTI is an index equity fund tracking the US total market. Over the year to Sep 11, 2026 it returned +17.2% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.03% a year. By its holdings filed for Jun 30, 2026, 88% of the fund by weight is stocks the S&P 500 also holds, across 3531 positions, with the top ten at 32.1%.
XBI in plain words
XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Jun 30, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 150 positions, with the top ten at 13.3%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, VTI or XBI?
- In the year to Sep 12, 2026, with distributions reinvested, VTI returned +17.2% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, VTI or XBI?
- VTI charges 0.03% a year and XBI charges 0.35%, so VTI is cheaper. Fees come from each fund's prospectus.
- How much do VTI and XBI overlap with the S&P 500?
- By their latest filed holdings, 88% of VTI and 8% of XBI by weight is stocks the S&P 500 already holds. Between the two funds, 2% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, VTI against XBI, data as of Sep 12, 2026. https://etfiq.com/compare/any/VTI-XBI Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources